Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Clinical trial NCT02483975 · COMPLETED
Trial details
- NCT number
- NCT02483975
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-09
- Primary completion
- 2016-06-20
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.